Home > News > Recent cases

Sandoz Ltd & Ors v Bristol-Myers Squibb Holdings [2022] EWHC 822 (Pat)7 April 2022Michael Tappin QC appeared as lead counsel for Sandoz in proceedings brought with Teva to revoke a patent owned by Bristol-Myers Squibb (“BMS”).  BMS counterclaimed for infringement, which, in the event that the patent was found to be valid, Sandoz and Teva admitted. The patent related to the compound apixaban sold by BMS under the […]
Ed Sheeran -v- Chokri [2022] EWHC 827 (Ch)6 April 2022Jessie Bowhill acted for Ed Sheeran and others, the co-writers and publishers of the biggest selling song of 2017; “Shape of You”. In his Judgment of 6 April 2022 Zacaroli J held that they had not infringed any copyright of the Defendants in creating and exploiting that song.
CommScope Technologies LLC v SOLiD Technologies Inc [2022] EWHC 769 (Pat)1 April 2022James Abrahams QC appeared as lead counsel for the Claimant (“CommScope”) in proceedings brought against the Defendant (“SOLiD”) for patent infringement. The patents (“EP626” and “EP850”) related to distributed antenna systems (“DAS”) used in cellular wireless communications to distribute radio frequency signals transmitted from a base station into areas where the signal has been significantly […]
Neurim Pharmaceuticals (1991) Ltd & Anr v Generics UK Ltd & Anr [2022] EWCA Civ 35929 March 2022Andrew Lykiardopoulos QC appeared as lead counsel for the Claimants (“Neurim” and “Flynn” respectively) in an appeal against the orders of Marcus Smith J dated 30 December 2020 and 12 March 2021.  The Claimants alleged that the Defendants (“Mylan”) had infringed a second medical use patent claiming the prolonged release of melatonin for the purposes […]
Optis Cellular Technology LLC & Ors v Apple Retail UK Ltd & Ors [2022] EWHC 561 (Pat)15 March 2022James Whyte and Jennifer Dixon, led by Thomas Hinchliffe QC, appeared for the Claimants (“Optis”) and Charlotte May QC and Lindsay Lane QC appeared as lead counsel for the Defendants (“Apple”) in Trial D, the latest trial in the ongoing proceedings between these parties.  The wider proceedings relate to eight telecommunications patents owned by Optis […]